February 24, 2017 / 1:16 PM / 6 months ago

BRIEF-Bioblast Pharma posts Q4 loss per share of $0.19

Feb 24 (Reuters) - Bioblast Pharma Ltd

* Bioblast pharma reports fourth quarter and year end 2016 financial results

* Q4 loss per share $0.19

* Bioblast pharma ltd - cash, cash equivalents and short-term bank deposits as of December 31, 2016 were $9.9 million Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below